Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
6.15
-0.17 (-2.69%)
At close: Mar 12, 2026, 4:00 PM EDT
6.11
-0.04 (-0.65%)
After-hours: Mar 12, 2026, 6:58 PM EDT
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $451 million as of March 12, 2026. Its market cap has increased by 5,269.07% in one year.
Market Cap
451.00M
Enterprise Value
437.12M
1-Year Change
5,269.07%
Ranking
Category
Stock Price
$6.15
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $451.00M, an increase of 696.82%. That is a compound annual growth rate of 21.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 463.50M | 30.86% |
| Dec 31, 2025 | 354.20M | 2,156.05% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
| Sep 30, 2015 | 56.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Century Therapeutics | 490.44M |
| Forte Biosciences | 488.22M |
| Entrada Therapeutics | 486.00M |
| Atea Pharmaceuticals | 486.00M |
| REGENXBIO | 484.13M |
| Aclaris Therapeutics | 479.86M |
| Assembly Biosciences | 462.02M |
| enGene Holdings | 460.89M |